S146: VENETOCLAX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION: 6-YEAR FOLLOW-UP AND GENOMIC ANALYSES IN A PIVOTAL PHASE 2 TRIAL
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000843476.36877.79 |
| _version_ | 1827335158804512768 |
|---|---|
| author | S. Stilgenbauer E. Tausch A. W. Roberts M. S. Davids B. Eichhorst M. Hallek P. Hillmen C. Schneider S. Böttcher R. Popovic M. T. Ghanim M. Moran W. J. Sinai X. Wang N. Mukherjee B. Chyla W. G. Wierda J. F. Seymour |
| author_facet | S. Stilgenbauer E. Tausch A. W. Roberts M. S. Davids B. Eichhorst M. Hallek P. Hillmen C. Schneider S. Böttcher R. Popovic M. T. Ghanim M. Moran W. J. Sinai X. Wang N. Mukherjee B. Chyla W. G. Wierda J. F. Seymour |
| author_sort | S. Stilgenbauer |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:11:04Z |
| format | Article |
| id | doaj.art-7176cf0f3fb2482e8cc0556a6086b189 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:11:04Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-7176cf0f3fb2482e8cc0556a6086b1892024-03-02T07:47:13ZengWileyHemaSphere2572-92412022-06-016474810.1097/01.HS9.0000843476.36877.79202206003-00047S146: VENETOCLAX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION: 6-YEAR FOLLOW-UP AND GENOMIC ANALYSES IN A PIVOTAL PHASE 2 TRIALS. Stilgenbauer0E. Tausch1A. W. Roberts2M. S. Davids3B. Eichhorst4M. Hallek5P. Hillmen6C. Schneider7S. Böttcher8R. Popovic9M. T. Ghanim10M. Moran11W. J. Sinai12X. Wang13N. Mukherjee14B. Chyla15W. G. Wierda16J. F. Seymour171 Division of CLL, Internal Medicine III, Ulm University, Ulm, Germany1 Division of CLL, Internal Medicine III, Ulm University, Ulm, Germany2 Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, Australia3 Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America4 Department of Internal Medicine, Center of Integrated Oncology Köln Bonn, University Hospital of Cologne, Cologne, Germany4 Department of Internal Medicine, Center of Integrated Oncology Köln Bonn, University Hospital of Cologne, Cologne, Germany5 Leeds Teaching Hospitals, NHS Trust, Leeds, United Kingdom1 Division of CLL, Internal Medicine III, Ulm University, Ulm, Germany6 Division of Internal Medicine, Medical Clinic III-Hematology, Oncology and Palliative Medicine, Rostock University Medical Center, Rostock, Germany7 AbbVie Inc, North Chicago, IL7 AbbVie Inc, North Chicago, IL7 AbbVie Inc, North Chicago, IL7 AbbVie Inc, North Chicago, IL7 AbbVie Inc, North Chicago, IL7 AbbVie Inc, North Chicago, IL7 AbbVie Inc, North Chicago, IL8 The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America2 Peter MacCallum Cancer Centre, Royal Melbourne Hospital, and University of Melbourne, Melbourne, Australiahttp://journals.lww.com/10.1097/01.HS9.0000843476.36877.79 |
| spellingShingle | S. Stilgenbauer E. Tausch A. W. Roberts M. S. Davids B. Eichhorst M. Hallek P. Hillmen C. Schneider S. Böttcher R. Popovic M. T. Ghanim M. Moran W. J. Sinai X. Wang N. Mukherjee B. Chyla W. G. Wierda J. F. Seymour S146: VENETOCLAX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION: 6-YEAR FOLLOW-UP AND GENOMIC ANALYSES IN A PIVOTAL PHASE 2 TRIAL HemaSphere |
| title | S146: VENETOCLAX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION: 6-YEAR FOLLOW-UP AND GENOMIC ANALYSES IN A PIVOTAL PHASE 2 TRIAL |
| title_full | S146: VENETOCLAX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION: 6-YEAR FOLLOW-UP AND GENOMIC ANALYSES IN A PIVOTAL PHASE 2 TRIAL |
| title_fullStr | S146: VENETOCLAX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION: 6-YEAR FOLLOW-UP AND GENOMIC ANALYSES IN A PIVOTAL PHASE 2 TRIAL |
| title_full_unstemmed | S146: VENETOCLAX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION: 6-YEAR FOLLOW-UP AND GENOMIC ANALYSES IN A PIVOTAL PHASE 2 TRIAL |
| title_short | S146: VENETOCLAX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION: 6-YEAR FOLLOW-UP AND GENOMIC ANALYSES IN A PIVOTAL PHASE 2 TRIAL |
| title_sort | s146 venetoclax in patients with chronic lymphocytic leukemia with 17p deletion 6 year follow up and genomic analyses in a pivotal phase 2 trial |
| url | http://journals.lww.com/10.1097/01.HS9.0000843476.36877.79 |
| work_keys_str_mv | AT sstilgenbauer s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT etausch s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT awroberts s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT msdavids s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT beichhorst s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT mhallek s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT phillmen s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT cschneider s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT sbottcher s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT rpopovic s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT mtghanim s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT mmoran s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT wjsinai s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT xwang s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT nmukherjee s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT bchyla s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT wgwierda s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial AT jfseymour s146venetoclaxinpatientswithchroniclymphocyticleukemiawith17pdeletion6yearfollowupandgenomicanalysesinapivotalphase2trial |